Together, the significant increase in NTSR2 mRNA and protein levels suggested that NTSR2 plays a role in the pathogenesis of B-CLL, regardless of the biological and clinical features of this disease. The gene discussed is NTSR2; the disease is B-cell chronic lymphocytic leukemia.